HC
Helen Louise Collins (CHIEF MEDICAL OFFICER) filed 11 Form 4 reports in the trailing twelve months (0 purchases, 11 sales), most often in Enliven Therapeutics, Inc. (ELVN). The largest single filing was $1.4M of ELVN (40,000 sh × $35.10, as filed), executed Mar 25. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
11
0 buys · 11 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$5.2M
shares × price, as filed
Last traded
Oct 19
Filed Oct 21
Median ADV $83.7M across their filed names
Open performance→Volume by month
Buys $0
Sells $5.2M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
11 filings
Sector per market data · by filing · past 12 months
Most traded names
ELVNRecent filings
ELVNSALE
Enliven Therapeutics, Inc.
View filing →
$139K5,000 sh × $27.76
Exec Mar 17
Filed Mar 19 · 5:30 PM ET ELVNSALE Enliven Therapeutics, Inc. View filing → $1.2M
40,000 sh across 2 lots
Exec Mar 9
Filed Mar 11 · 5:30 PM ET ELVNSALE Enliven Therapeutics, Inc. View filing → $1.2M
45,000 sh × $26.17
Exec Feb 17
Filed Feb 19 · 5:30 PM ET